Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form
D-Scholarship @ Pitt Banner and Links to Homepage

Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro

Francavilla, A and Carr, BI and Azzarone, A and Polimeno, L and Wang, Z and Van Thiel, DH and Subbotin, V and Prelich, JG and Starzl, TE (1994) Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology, 20 (5). 1237 - 1241. ISSN 0270-9139

[img]
Preview
 PDF
Accepted Version
Available under License : See the attached license file.
Download (1MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)

Abstract

Subcutaneous injections of hormone triiodothyronine in rats resulted in peak blood levels at 24 hr with return to baseline by 96 hr. The injections stimulated a liver regeneration response that resembled in timing and in magnitude of DNA synthesis (peak, 24 hr) that induced by 40% hepatic resection. The principal proliferation was of hepatocytes. Although there were some temporal differences from the gene expression of transforming growth factor‐α, transforming growth factor‐β, and c‐Ha‐ras that are known to follow partial hepatectomy, the overall profile of these changes was similar to those after partial resection. The effect was liver specific and could be reproduced three times with no diminution in response in the same animal with injections at 10‐day intervals. No response was detected in kidney or intestine. This effect in intact animals contrasted with the minimal ability of triiodothyronine to stimulate hepatocytes in culture. However, when the culture medium was enriched with epidermal growth factor, there was a dose‐related response to triiodothyronine. The totality of these experiments provides a preliminary basis for the creation with pharmacological techniques of an in vivo hyperplastic hepatic condition permissive of transfection of new genes, as an alternative to partial hepatectomy. Although triiodothyronine was the test agent used, other hepatic growth factors singly or in combination could be candidates for this purpose. (Hepatology 1994;20:1237–1241). Copyright © 1994 American Association for the Study of Liver Diseases

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Francavilla, A
Carr, BI
Azzarone, A
Polimeno, L
Wang, Z
Van Thiel, DH
Subbotin, V
Prelich, JG
Starzl, TEtes11@pitt.eduTES11
Centers: Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute
Date: 1 January 1994
Date Type: Publication
Journal or Publication Title: Hepatology
Volume: 20
Number: 5
Page Range: 1237 - 1241
DOI or Unique Handle: 10.1002/hep.1840200521
Institution: University of Pittsburgh
Refereed: Yes
ISSN: 0270-9139
Other ID: uls-drl:31735062124742, Starzl CV No. 1675
Date Deposited: 08 Apr 2010 17:28
Last Modified: 15 Jun 2019 09:55
URI: http://d-scholarship.pitt.edu/id/eprint/5061

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

Actions (login required)

View Item View Item